Newsletter | February 21, 2026

02.21.26 -- The Case For Research-Naive PIs

CLINICAL SITES

The Case For Research-Naive PIs

Central eSource Is The Latest In Sponsor Provided Site Offerings

Investigator Databank And DQS: Welcoming New Consortium Members

Debunking 5 Misconceptions About Community-Based Research Sites

PATIENT CENTRICITY

Heard At SCOPE: Pharma Wants ROI For Patient Data Return, Diverse Enrollment

The Value Of Patient-Reported Outcomes In Cancer Clinical Research

Hope In The Dark: Value In Alzheimer's Disease Research And Treatment

PATIENT RECRUITMENT

Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients?

CLINICAL TRIAL TECHNOLOGY

Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders

Improving The eCOA Experience

Hospital-Based eCOA Implementation

Ensuring Timeliness, Completeness, And Quality With Digital Solutions

TRIAL MANAGEMENT

Making Medical Innovation Matter To Patients With Simplified Trial Design

Empowering Patients With Self-Administration Drug Delivery Devices

Global Reach, Biotech Speed: Clinical Packaging, Labeling That Delivers

10 HEOR Trends

Human-Centered RTSM Design Enhances Data, Safety, And Operations

DECENTRALIZED TRIALS

Where The FDA And EMA Stand On Digital Endpoints

Virtual Clinical Trials For Ophthalmic Measures

REGULATORY & COMPLIANCE

From Lab To Launch: Navigating The Transition To Commercial Readiness

Why Big Pharma Is Shifting Toward FSP Solutions

Five Ways Site-Facing Technology Helps Sponsors And CROs

De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept

Why Biotech CRO Partnerships Are Essential For Clinical Trial Success

OUTSOURCING MODELS

Could Moving To This Swiss Life Sciences Hub Be In Your Company's Future?

Is Your Clinical Trial Portfolio CTIS Compliant?

What The FDA Looks For In Global Development Programs Today

Is Your Clinical Research Site GCP-Ready?

EU GMP Annex 11: Compliance Strategy And Digital Solutions

CLINICAL DATA MANAGEMENT & ANALYTICS

Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate

The Connected Patient In Clinical Trials

Empower Your Trial With Data And Evidence

A New, AI-Augmented Horizon For Safety And Pharmacovigilance

Changing The Clinical Feasibility Game With AI

TRIAL MONITORING

How To Meet FDA Expectations For Hybrid And Decentralized Trial Oversight

Reducing Risk With Shift Left Testing

Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints

Connect With Clinical Leader: